The purpose of this study is to determine if the use of Tepotinib with or without Ramucirumab is effective in patients with MET Exon 14 skipping positive stage 4 or recurrent non-small cell lung cancer (NSCLC).(LUNGMAP sub-study)
Contact phone
Tracy Bellefeuil | (517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Metastatic Non-Small Cell Lung
Webform